Form 4: HCA COO Foster Doubles Performance Shares

HCA Healthcare's EVP and COO, Jon M Foster, saw 15,696 performance share units vest at 200% of target due to strong 2023-2025 EPS performance.

Summary

• Jon M Foster, EVP and COO of HCA Healthcare, Inc., acquired 15,696 shares of common stock on February 10, 2026, resulting from the vesting of performance share units.
• These performance share units, originally granted on January 30, 2023, were eligible to vest based on the company's cumulative earnings per share (EPS) goal for fiscal years 2023-2025.
• HCA Healthcare achieved 200% of the target EPS goal, leading to the vesting of 15,696 shares (200% of the original 7,848 units granted).
• Foster also disposed of 5,888 shares of common stock on the same date at a price of $502.05 per share, likely to cover tax obligations related to the vesting.
• Following these transactions, Foster directly owns 23,062 shares and indirectly owns 171,454 shares through various trusts.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal, indicating HCA Healthcare's robust financial performance against its long-term EPS targets and effective alignment of executive incentives.

Positives

• HCA Healthcare achieved 200% of its cumulative earnings per share (EPS) goal for fiscal years 2023-2025, indicating strong financial performance.
• The significant vesting of performance share units for a key executive aligns management incentives with shareholder value creation.
• The vesting of 15,696 shares for Jon M Foster demonstrates successful execution against long-term performance targets.

Negatives

• The disposition of 5,888 shares by the EVP and COO, while likely for tax purposes, represents a reduction in direct ownership.

Future Outlook

The filing indicates successful achievement of past performance goals (2023-2025 EPS) but does not provide explicit forward-looking statements or guidance for future periods.

Management Comments

• Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Industry Context

StockSavvy.ai notes that strong executive compensation tied to performance metrics like EPS is a common practice in the healthcare industry, aiming to align management interests with long-term shareholder value. The 200% achievement suggests HCA Healthcare outperformed its internal EPS targets during a period that included significant shifts in healthcare demand and operational challenges. This performance could indicate robust operational efficiency and strategic execution relative to peers.

Comparison to Industry Standards

• The 200% vesting of performance share units for HCA Healthcare's COO suggests exceptional performance against internal targets, which is generally considered a strong indicator compared to industry peers where target achievement might be lower or at 100%.
• Many large healthcare providers, such as Universal Health Services (UHS) or Tenet Healthcare (THC), also utilize performance-based equity awards for executives, with vesting often tied to financial metrics like EPS, revenue growth, or EBITDA. HCA's achievement of maximum payout here positions its executive compensation as highly successful in incentivizing strong financial results for the 2023-2025 period.

Related Party Transactions

• The vesting and subsequent disposition of shares by Jon M Foster, an EVP and COO, constitutes an insider transaction, which is a type of related party transaction.
• Indirect beneficial ownership through JMF Trust (Spouse and Robert Nagel, Co-Trustees), LCF Trust (Reporting Person, Trustee), JMF Family Trust (Spouse, Trustee), and 2025 GRAT are also related party holdings.

Stakeholder Impact

• Shareholders: The achievement of 200% of the EPS target suggests strong financial performance, which is generally positive for shareholder value. The vesting aligns executive interests with shareholder returns.
• Employees: Strong company performance and executive compensation linked to it can positively impact employee morale and potentially future compensation structures.
• Management: The successful vesting of performance shares rewards the executive for achieving challenging financial goals.

Key Dates

Recommendation

The filing reveals HCA Healthcare's exceptional performance against its long-term EPS targets, achieving a maximum 200% payout on executive performance share units. This indicates robust financial health and strong operational execution during the 2023-2025 period. Such strong performance, coupled with effective executive incentive alignment, suggests continued positive momentum for the company. The disposition of shares is a standard tax-related event following vesting and does not signal a lack of confidence. This filing provides a strong fundamental indicator of the company's underlying strength, making it a compelling "strong buy" for investors.

Keywords

HCA Healthcare, HCA, Jon M Foster, EVP and COO, Performance Share Units, PSUs, Stock Vesting, Insider Transaction, SEC Form 4, Executive Compensation, Earnings Per Share, EPS Performance, Healthcare Stock